Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 144Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Leukemia 52Hodgkin Disease 49Lymphoma, Non-Hodgkin 47Multiple Myeloma 43Myeloproliferative Disorders 39Lymphoma 36Leukemia, Lymphocytic, Chronic, B-Cell 36Primary Myelofibrosis 24Leukemia, Biphenotypic, Acute 22Leukemia, Myelomonocytic, Chronic 21Hematologic Neoplasms 20Graft vs Host Disease 18Anemia, Refractory, with Excess of Blasts 17Anemia, Aplastic 14Lymphoma, Mantle-Cell 13Lymphoma, Follicular 13Lymphoma, B-Cell, Marginal Zone 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Leukemia, Prolymphocytic 11Blast Crisis 10Polycythemia Vera 8Leukemia, Myelomonocytic, Juvenile 8Hematologic Diseases 8Leukemia, Lymphoid 7Thrombocythemia, Essential 6

Interventions

AP 1903 reagent 3ON 01910 2thymoglobulin 1fludarabine phosphate 1fludarabine 1epacadostat 1cedazuridine 1Therapeutics 1Sertraline 1Peripheral Blood Stem Cell Transplantation 1Interleukin-8 1IDO-1 inhibitor LY3381916 1HuMax-IL8 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Exercise 1Decitabine 1DNA 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Bone Marrow Transplantation 1Biopsy 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytopenia × fludarabine × Myeloid × Clear all
NCT02143830 2025-11-12

RAFA

Children's Hospital Medical Center, Cincinnati

Phase 2 Recruiting
70 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Cytopenia, Anemia, Refractory, with Excess of Blasts, Fanconi Anemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡